Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Pingxiang People's Hospital

Pingxiang, 337000, KínaMég nincs intézményhez kötve

38futó vizsgálat
20lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 58 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Elhízás8 vizsgálat
2-es típusú cukorbetegség7 vizsgálat
Lupus (SLE)7 vizsgálat
Stroke (szélütés)5 vizsgálat
Arthritis psoriatica4 vizsgálat
Pikkelysömör4 vizsgálat
Krónikus obstruktív tüdőbetegség (COPD)3 vizsgálat
Liver cirrhosis3 vizsgálat
Szívelégtelenség3 vizsgálat
Zsírmáj (MASLD/MASH)3 vizsgálat
Asztma2 vizsgálat
Bronchiectasis2 vizsgálat
és még 16
Fázis: 3. fázis37 vizsgálat
2. fázis11 vizsgálat
1. fázis3 vizsgálat
1/2. fázis3 vizsgálat
2/3. fázis3 vizsgálat
Állapot: Toboroz21 vizsgálat
Lezárult19 vizsgálat
Még nem toboroz9 vizsgálat
Fut, nem toboroz7 vizsgálat
Meghívásos bevonás1 vizsgálat
Leállították1 vizsgálat
Fő szponzor: Boehringer Ingelheim10 vizsgálat
Janssen Research & Development, LLC4 vizsgálat
Eli Lilly and Company3 vizsgálat
Hoffmann-La Roche3 vizsgálat
Pfizer3 vizsgálat
és még 31

Futó vizsgálatok

Még nem toboroz
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
NCT07629583· 1. fázis· Genentech, Inc.· Forrás
Toboroz
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
NCT07792954· 3. fázis· Pfizer· Forrás
Toboroz
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07795346· 3. fázis· Antengene Biologics Limited· Forrás
Contact: Zhiqiang Zhan
Toboroz
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
NCT07687186· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás
Contact: Yuhong Zhang
Toboroz
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245· 2. fázis· Eli Lilly and Company· Forrás
Contact: Xiangbo Shen (principal investigator)
Toboroz
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT07406035· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Senhua Dai, Master
Toboroz
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152· 3. fázis· Xiamen Amoytop Biotech Co., Ltd.· Forrás
Contact: Guangping Qin
Toboroz
A Study of E6742 in Participants With Systemic Lupus Erythematosus
NCT07515014· 2. fázis· Eisai Co., Ltd.· Forrás
Toboroz
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
NCT07447986· 2. fázis· Hangzhou Sumgen Biotech Co., Ltd.· Forrás
Contact: Senhua Dai, Master
Toboroz
A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis
NCT07453004· 2. fázis· TJ Biopharma Co., Ltd.· Forrás
Contact: Senhua Dai
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Még nem toboroz
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）
NCT07274137· 3. fázis· MindRank AI Ltd· Forrás
Contact: Yawei Zhang
Toboroz
A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
NCT07323173· 1. fázis· Nanjing Leads Biolabs Co.,Ltd· Forrás
Contact: lei liu
Toboroz
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
NCT07641634· 1/2. fázis· Prolium Bioscience, Inc· Forrás
Contact: Sergio Rodriguez
Toboroz
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028· 3. fázis· Eli Lilly and Company· Forrás
Contact: Xing Li (principal investigator)
Fut, nem toboroz
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
NCT07153471· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714· 2. fázis· Mabwell (Shanghai) Bioscience Co., Ltd.· Forrás
Contact: Yongchang Sun, Doctor
Toboroz
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Még nem toboroz
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286· Peking University First Hospital· Forrás
Contact: Weiguo Chen
Toboroz
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
NCT06829784· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Contact: Limin Dong, Bachelor
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
NCT06878404· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
NCT06841042· 1/2. fázis· Sinocelltech Ltd.· Forrás
Contact: Jiankang Hu
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
NCT06807424· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
SIM0718 Treatment of Asthma Clinical Study
NCT06488755· 3. fázis· Simcere Pharmaceutical Co., Ltd· Forrás
Toboroz
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).
NCT06175351· 1/2. fázis· Mabwell (Shanghai) Bioscience Co., Ltd.· Forrás
Toboroz
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
NCT05744687· 2/3. fázis· Shanghai Pharmaceuticals Holding Co., Ltd· Forrás
Contact: An Xiao
Toboroz
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642· 2. fázis· Shanghai Pharmaceuticals Holding Co., Ltd· Forrás
Contact: Fei Yi
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Meghívásos bevonás
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
NCT05352919· 3. fázis· Biogen· Forrás
Fut, nem toboroz
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
NCT04882098· 3. fázis· Janssen Research & Development, LLC· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Lezárult
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229· 2. fázis· Atom Therapeutics Co., Ltd· Forrás
Lezárult
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
NCT06553456· 2/3. fázis· Beijing Protgen Biotechnology Development Co., Ltd.· Forrás
Lezárult
Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06415773· 3. fázis· Shenzhen HighTide Biopharmaceutical Ltd.· Forrás
Lezárult
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
NCT06250062· 2. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Lezárult
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
NCT05989048· 3. fázis· Pfizer· Forrás
Lezárult
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
NCT06066528· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
NCT06066515· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
NCT06144710· 1. fázis· Hangzhou Sumgen Biotech Co., Ltd.· Forrás
Lezárult
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
NCT06350890· 3. fázis· Shenzhen HighTide Biopharmaceutical Ltd.· Forrás
Leállították
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
NCT05849727· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Lezárult
Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial
NCT06429384· 2. fázis· Beijing Tiantan Hospital· Forrás
Lezárult
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
NCT05810038· 3. fázis· Pfizer· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia
NCT06355479· 3. fázis· Healthgen Biotechnology Corp.· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
NCT05673993· 3. fázis· RemeGen Co., Ltd.· Forrás
Lezárult
rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
NCT05700591· 3. fázis· Tasly Biopharmaceuticals Co., Ltd.· Forrás
Lezárult
A Study of IBI362 in Participants With Obesity or Overweight
NCT05607680· 3. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Lezárult
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
NCT05439629· 3. fázis· Bio-Thera Solutions· Forrás
Lezárult
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
NCT06500689· 3. fázis· Shenzhen Salubris Pharmaceuticals Co., Ltd.· Forrás
Lezárult
Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
NCT05003245· 3. fázis· Shanghai Henlius Biotech· Forrás
Lezárult
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT04619797· 2/3. fázis· Hoffmann-La Roche· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 13.

Építés alatt, nem éles – Pingxiang People's Hospital: vizsgálati helyszín – Frontlight Research